Ishihara Chemical Co., Ltd. (TYO:4462)
Japan · Delayed Price · Currency is JPY 2,664.00
-8.00 (-0.30%)
Jun 4, 2026, 10:48 AM JST
Ishihara Chemical Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 23,450 | 23,630 | 20,705 | 20,345 | 19,036 | |
Revenue Growth (YoY) | -0.76% | 14.13% | 1.77% | 6.88% | 12.19% |
Cost of Revenue | 14,829 | 15,625 | 14,026 | 14,079 | 12,764 |
Gross Profit | 8,621 | 8,005 | 6,679 | 6,266 | 6,272 |
Selling, General & Admin | 4,779 | 3,418 | 3,190 | 3,030 | 2,867 |
Research & Development | - | 1,186 | 1,160 | 1,096 | 1,050 |
Operating Expenses | 4,779 | 4,604 | 4,350 | 4,126 | 3,917 |
Operating Income | 3,842 | 3,401 | 2,329 | 2,140 | 2,355 |
Interest Expense | -2 | - | - | -1 | - |
Interest & Investment Income | 70 | 60 | 49 | 57 | 57 |
Currency Exchange Gain (Loss) | 42 | -38 | 31 | 13 | 41 |
Other Non Operating Income (Expenses) | 41 | 36 | 46 | 51 | 63 |
EBT Excluding Unusual Items | 3,993 | 3,459 | 2,455 | 2,260 | 2,516 |
Gain (Loss) on Sale of Investments | 160 | 43 | 167 | 157 | 286 |
Asset Writedown | -2 | -91 | -1 | -3 | -1 |
Pretax Income | 4,151 | 3,411 | 2,621 | 2,414 | 2,801 |
Income Tax Expense | 1,182 | 946 | 715 | 730 | 752 |
Net Income | 2,969 | 2,465 | 1,906 | 1,684 | 2,049 |
Net Income to Common | 2,969 | 2,465 | 1,906 | 1,684 | 2,049 |
Net Income Growth | 20.45% | 29.33% | 13.18% | -17.81% | 36.24% |
Shares Outstanding (Basic) | 14 | 14 | 15 | 15 | 16 |
Shares Outstanding (Diluted) | 14 | 14 | 15 | 15 | 16 |
Shares Change (YoY) | -3.88% | -4.92% | -2.11% | -3.14% | -1.87% |
EPS (Basic) | 217.30 | 173.42 | 127.50 | 110.27 | 129.96 |
EPS (Diluted) | 217.30 | 173.42 | 127.50 | 110.27 | 129.96 |
EPS Growth | 25.30% | 36.02% | 15.62% | -15.15% | 38.83% |
Free Cash Flow | 2,631 | 3,202 | 1,155 | 552 | 1,561 |
Free Cash Flow Per Share | 192.56 | 225.27 | 77.26 | 36.15 | 99.01 |
Dividend Per Share | - | 40.000 | 36.000 | 34.000 | 26.500 |
Dividend Growth | - | 11.11% | 5.88% | 28.30% | 23.26% |
Gross Margin | 36.76% | 33.88% | 32.26% | 30.80% | 32.95% |
Operating Margin | 16.38% | 14.39% | 11.25% | 10.52% | 12.37% |
Profit Margin | 12.66% | 10.43% | 9.21% | 8.28% | 10.76% |
Free Cash Flow Margin | 11.22% | 13.55% | 5.58% | 2.71% | 8.20% |
EBITDA | 4,436 | 3,940 | 2,842 | 2,679 | 2,846 |
EBITDA Margin | 18.92% | 16.67% | 13.73% | 13.17% | 14.95% |
D&A For EBITDA | 594 | 539 | 513 | 539 | 491 |
EBIT | 3,842 | 3,401 | 2,329 | 2,140 | 2,355 |
EBIT Margin | 16.38% | 14.39% | 11.25% | 10.52% | 12.37% |
Effective Tax Rate | 28.48% | 27.73% | 27.28% | 30.24% | 26.85% |